Womens Health Diagnostics Market

Quest Diagnostics Incorporated (US), Hologic, Inc. (US), and F. Hoffmann-La Roche Ltd. (Switzerland) are the Leading Players in the women’s Health Diagnostics Market

The women’s health diagnostics market is projected to reach USD 36.6 billion by 2025 from USD 25.0 billion in 2020, at a CAGR of 7.9% during the forecast period. The growing awareness about various health-related disorders, rising incidence of chronic and lifestyle disorders, and the high prevalence of infectious diseases such as HIV and hepatitis in women across the globe, increasing adoption of POC diagnostic testing and the growth in the number of diagnostic and imaging centers support the growth of the market. However, the high cost of diagnostic devices, tests, and procedures; shortage of skilled laboratory technicians; and insufficient reimbursements for diagnostic tests are expected to restrain this markets growth to a certain extent.

The women’s health diagnostics market is highly competitive. The prominent companies in this market are Quest Diagnostics Incorporated (US), Hologic, Inc. (US), Siemens AG (Germany), PerkinElmer, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health, Inc. (US), General Electric Company (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), bioMérieux SA (France), Koninklijke Philips N.V. (Netherlands), Guided Therapeutics, Inc. (US), SuperSonic Imagine (France), FUJIFILM Holdings Corporation (Japan), DIALAB GmbH (Austria), Carestream Health, Inc. (US), MedGyn Products, Inc. (US), Cook Medical, Inc. (US), Osteometer MediTech, Inc. (Denmark), and NeuroLogica Corporation (US).

To know about the assumptions considered for the study download the pdf brochure

New product launches and acquisitions were the key strategies adopted by major companies to expand their presence in the global women’s health diagnostics market.

Hologic, Inc. holds the leading position in the women’s health diagnostics market, owing to its robust portfolio of breast imaging products and related accessories. Hologic has expanded its product portfolio through insight-driven innovation and strategic M&As to establish its position in the market. During the last three years, Hologic launched several systems and software, such as Unifi Analytics, the new Viera Portable Breast Ultrasound System, the Brevera Breast Biopsy System with CorLumina Imaging Technology, and the 3Dimensions Mammography System, in Europe.

Quest Diagnostics is the world’s leading provider of diagnostic information services and solutions. The company offers a broad portfolio of solutions in women’s health. These solutions span across areas of oncology, STDs, UTIs, HIV, pregnancy, and prenatal testing. The company has strategically enhanced its presence in the global women’s health diagnostics market by opting for organic growth strategies, such as product launches. In April 2019, the company launched three new sexually transmitted disease laboratory test packages.

Related Reports:

Women’s Health Diagnostics Market by Application (Biopsy, Cervical & Ovarian Cancer Testing, PAP Smear, HPV, TORCH, Prenatal Testing, Hepatitis, Ultrasound, Obstetrics), End User (Hospitals, Clinics, Home Care), COVID-19 Impact – Global Forecast to 2025

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Womens Health Diagnostics Market Size,  Share & Growth Report
Report Code
MD 4774
RI Published ON
Choose License Type

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status